药物对比
Linagliptin vs Nateglinide
比较 Linagliptin（Tradjenta）与 Nateglinide 治疗2型糖尿病。DPP-4与格列奈类：A1C疗效、低血糖风险和餐时给药。
此页面暂无可用的对比维度。
临床背景
This comparison arises when adding an oral agent for type 2 diabetes, choosing between overall glycemic control and postprandial targeting.
结论
Linagliptin is often preferred for convenience and safety, while nateglinide suits mealtime glucose control needs.
全部药物对比